MedTrace Logo

Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis

NCT03809754 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2019-01-23

No results posted yet for this study

Summary

This study is a prospective, registry trial aimed to compare the clinical and angiographic outcomes of OCT-guided and angiography-guided PCI in patients with coronary DES-ISR.

Conditions

  • CHD - Coronary Heart Disease
  • Percutaneous Coronary Intervention
  • In-stent Restenosis

Interventions

PROCEDURE

Percutaneous Coronary Intervention under OCT

After randomization, subjects receive primary PCI under the guiding of OCT

PROCEDURE

Percutaneous Coronary Intervention under Angiography

After randomization, subjects receive primary PCI under the guiding of angiography

Sponsors & Collaborators

  • Chinese PLA General Hospital

    lead OTHER

Principal Investigators

  • Yundai Chen · Chinese PLA General Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-03-01
Completion
2020-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03809754 on ClinicalTrials.gov